Some young cancer survivors face higher risk of premature heart failure
Those at higher risk had been treated with a specific category of chemotherapy
2023-05-16
(Press-News.org) Mean age at diagnosis of heart failure was 32 years old
First study to estimate risk of heart failure among young adult cancer survivors treated with this category of chemotherapy
Study raises awareness for patients, clinicians to monitor for heart failure symptoms, consider strategies for prevention
CHICAGO --- Imagine surviving cancer only to learn the drug that saved your life has introduced a completely different health risk: heart failure.
A new Northwestern Medicine study has found young adult cancer survivors (between 18 and 39 years old at diagnosis) were at higher risk (2.6 times) of heart failure when treated with anthracyclines, a specific category of chemotherapy that damages DNA in cancer cells.
The large study of 12,879 young adult cancer survivors is the first study to estimate the risk of heart failure among young adult cancer survivors treated with anthracyclines.
The incidence of heart failure was highest for cancer survivors of leukemia. Additionally, survivors of kidney, lymphoma, bone and breast cancer also had a higher incidence of heart failure compared with study participants diagnosed with other cancer types. These types of cancer are more likely to be treated with anthracyclines.
“Thankfully, people are increasingly surviving early onset cancer, but once they do, they’re at risk of long-term side effects, like heart failure and infertility,” said corresponding study author Elizabeth Hibler, assistant professor of epidemiology and prevention at Northwestern University Feinberg School of Medicine. “I’m interested in not only helping people survive their cancer, but once they do, helping them improve their health and longevity as cancer survivors.”
The study was published May 16 in the journal JACC: CardioOncology.
The mean age of heart failure diagnosis was 32 years old, which not only indicates an increased risk, but also early onset of heart failure, said senior study author Dr. Sadiya Khan.
“We often think about heart failure as a disease people get when they are old, but this work highlights that this is also a short-term risk for patients who survive cancer,” said Khan, assistant professor of cardiology and epidemiology at Feinberg and a Northwestern Medicine physician. “It raises awareness for patients and clinicians to monitor symptoms and consider strategies for prevention.”
More about anthracycline chemotherapy
The relationship between anthracycline chemotherapy and heart failure risk also has been shown among childhood and older adult cancer survivors, but this is the first study to estimate the risk of heart failure among the young adult population.
Hibler said while anthracycline chemotherapy is effective at treating cancer, physicians are moving away from it because of the cardiotoxic side effects.
“What we’re trying to do is apply our findings to studying other cancer medications to try to understand if they impact the heart,” Hibler said. “Our goal is to improve early detection because there are early treatments for heart failure if the patient is showing signs.”
The results of this study provide more evidence for the overlap between cardiovascular disease and cancer, but future research is needed to understand if other (newer) types of cancer treatment also can impact the risk of heart failure, even for young people, Hibler said. Future research also is needed to understand how shared risk factors can impact the risk of both cancer and heart disease.
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-05-16
Only four weeks of shift work-like patterns in female mice are enough to disrupt their biological clock and reduce fertility, according to research presented at the 25th European Congress of Endocrinology. The findings help scientists better understand how circadian disturbances impact female fertility, which could eventually lead to future prevention strategies for women working in non-standard work schedules.
The circadian rhythm is generated by the body’s internal clocks which are synchronised to a 24-hour period, mostly by changes in light across days. These clocks regulate various biological functions and processes, including the sleep-wake cycle, ...
2023-05-16
The board of governors of the SWOG Cancer Research Network has elected Primo N. Lara, Jr., MD, and Dawn L. Hershman, MD, MS, as group co-chairs-elect. The two will serve in that capacity until the term of the current group chair, Charles D. Blanke, MD, ends in spring 2025. They will then begin a six-year term as SWOG’s first group co-chairs.
In a joint statement, Hershman and Lara said, “We both understand that the success of SWOG has been fundamentally anchored in collaborative interdisciplinary team science. We are convinced ...
2023-05-16
Boulder, Colo., USA: The Geological Society of America (GSA) is pleased to announce the upcoming 2023 GSA Rocky Mountain Section Meeting to be held from 23–25 May in Fort Collins, Colorado, USA. This highly anticipated event will provide a dynamic platform for scientists, researchers, industry professionals, and students to exchange ideas, present research findings, and foster collaborations. The meeting will feature a wide range of engaging sessions, a plenary lecture on climate intervention, scientific field trips, informative short courses, and impactful mentoring programs ...
2023-05-16
COMBINEDBrain’s Founder and Director, Dr. Terry Jo Bichell, understands the power of collaboration. In her years as a neuroscientist, advocate, and rare patient parent, she has witnessed the field of neurodevelopment transform from a broad focus on autism or intellectual disability, to an era based on rare genetic disorders. When new disorders are identified, Patient Advocacy Organizations spring up, led by passionate parents with the drive and determination to cure their children. Some of these organizations represent as many as 10,000 patients, some as few as 10. No matter their size, each organization must follow a similar path to ...
2023-05-16
Liquid biopsy is increasingly stepping up as a non-invasive approach in detecting and tracking circulating tumor DNA (ctDNA) in blood and providing crucial insights into the dynamics of cancer evolution and intra-tumor heterogeneity as drivers of cancer drug resistance.
One main limitation of liquid biopsy to-date is the low sensitivity of current approaches in tumor types that do not shed enough DNA into the bloodstream, including pancreatic cancer.
Co-led by VHIO’s Rodrigo A. Toledo, a study published in Genome Medicine (1) reports on the development of a novel ctDNA-based approach, Aneuploidy in Circulating Tumor DNA ...
2023-05-16
Researchers at Rutgers University have found a major flaw in the way that algorithms designed to detect "fake news" evaluate the credibility of online news stories.
Most of these algorithms rely on a credibility score for the "source" of the article, rather than assessing the credibility of each individual article, the researchers said.
"It is not the case that all news articles published by sources labeled 'credible' (e.g., The New York Times) are accurate, nor is it the case that every article published by sources labeled 'noncredible' publications are 'fake news,'" ...
2023-05-16
Spooked by volatile reports from the Silicon Valley Bank in early March, many customers panicked and withdrew their money, creating the largest bank failure since the 2007-2008 financial crisis. The problem — investors and customers lost confidence in the bank, proving the perception of a banks’ reliability can significantly impact its success.
Investors tend to respond negatively to volatility in firms’ performance. To mitigate investors’ concerns, when some banks receive extremely high income, they occasionally delay reporting that amount until a later date when the income ...
2023-05-16
“[...] we have developed a fully automated calling algorithm for determining B and T cell clonality from NGS [next-generation sequencing] data, with greater sensitivity than previously developed models.”
BUFFALO, NY- May 16, 2023 – A new research paper was published in Oncotarget's Volume 14 on May 12, 2023, entitled, “Development and implementation of an automated and highly accurate reporting process for NGS-based clonality testing.”
B and T cells undergo random recombination of the VH/DH/JH portions of the immunoglobulin loci (B cell) and T-cell receptors before becoming ...
2023-05-16
“This study now links Msi 1 to PD-L1.”
BUFFALO, NY- May 16, 2023 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 9, entitled, “Increased expression of musashi 1 on breast cancer cells has implication to understand dormancy and survival in bone marrow.”
Breast cancer (BC) stem cells (CSCs) resist treatment and can exist as dormant cells in tissues such as the bone marrow (BM). Years before clinical diagnosis, BC cells (BCCs) could migrate from the primary site where the BM niche ...
2023-05-16
Irvine, Calif., May 16, 2023 — The MGAT5 glycosylation enzyme plays a crucial role in brain development, according to a study by University of California, Irvine researchers, a discovery that may contribute to new therapeutic purposes for neural stem cells.
Neurons, astrocytes and oligodendrocytes are the final mature cells of the brain and spinal cord formed by neural stem cells. Each has distinct and key functions. Neurons transmit signals, astrocytes help modify those signals, and oligodendrocytes ...
LAST 30 PRESS RELEASES:
[Press-News.org] Some young cancer survivors face higher risk of premature heart failure
Those at higher risk had been treated with a specific category of chemotherapy
